✦ LIBER ✦

Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients

✍ Scribed by J.N.BOUWES BAVINCK; A.DE BOER; B.J. VERMEER; M.M. HARTEVELT; F.J.VAN DER WOUDE; F.H.J. CLAAS; R. WOLTERBEEK; J.P. VANDENBROUCKE

Book ID: 108664468
Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 653 KB
Volume: 129
Category: Article
ISSN: 0007-0963
DOI: 10.1111/j.1365-2133.1993.tb11841.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Skin cancer in renal transplant recipien

Skin cancer in renal transplant recipients

✍ M. Liddington; A. J. Richardson; R. M. Higgins; Z. H. Endre; V. A. Venning; J. A 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

Update on the pathogenesis of post-trans

Update on the pathogenesis of post-transplant skin cancer in renal transplant recipients

✍ W.L. Ho; G.M. Murphy 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Skin-cancer awareness in Scottish cardia

Skin-cancer awareness in Scottish cardiac transplant recipients

✍ S. Tavadia; G. Dawn; C. Payne; V. Ramrakha-Jones; A. Murday; S. Holmes 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Azathioprine dosage and metabolite studi

Azathioprine dosage and metabolite studies in renal transplant recipients with premalignant and malignant skin lesions

✍ S.E. Thomas; L. Lennard; C.I. Harrington; J.L. Maddocks; C. Brown 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

Management of skin cancer in solid organ

Management of skin cancer in solid organ transplant recipients

✍ Carmen Traywick; Fiona M. O'Reilly 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Acitretin for chemoprevention of non-mel

Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients

✍ Renu George; Warren Weightman; Graeme R Russ; Kym M Bannister; Timothy H Mathew 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

## SUMMARY A prospective, open randomized crossover trial was conducted to evaluate the efficacy of acitretin for chemoprevention of squamous cell carcinomas and basal cell carcinomas in renal allograft recipients. Analysis was performed according to the intention‐to treat principle. Twenty‐three p